Evidence map›Paper›PMID 21127054›Full record

ArticleThe Journal of biological chemistry2011

Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic beta cells.

Veronica Dominguez, Claudio Raimondi, Sangeeta Somanath, Marco Bugliani, Merewyn K Loder, Charlotte E Edling, Nullin Divecha, Gabriela da Silva-Xavier, Lorella Marselli, Shanta J Persaud and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 5 pooled it
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 5 syntheses or guidelines pooled it, 160 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Effect ofWorld journal of diabetes · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Veronica DominguezFrom the Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute of Cell and Molecular Science, Centre for Diabetes, London E1 2AT, United Kingdom.
Claudio Raimondi
Sangeeta Somanath
Marco Bugliani
Merewyn K Loder
Charlotte E Edling
Nullin Divecha
Gabriela da Silva-Xavier
Lorella Marselli
Shanta J Persaud
Mark D Turner
Guy A Rutter
Piero Marchetti
Marco Falasca
Tania Maffucci
Queen Mary University of London · GBImperial College London · GBUniversity of Pisa · ITCancer Research UK Manchester Institute · GBKing's College London · GB

Funding

Diabetes UK 13/0004672Medical Research Council G0401641Wellcome Trust
6 · The paper itself

Abstract

Phosphoinositide 3-kinases (PI3Ks) are critical regulators of pancreatic β cell mass and survival, whereas their involvement in insulin secretion is more controversial. Furthermore, of the different PI3Ks, the class II isoforms were detected in β cells, although their role is still not well understood. Here we show that down-regulation of the class II PI3K isoform PI3K-C2α specifically impairs insulin granule exocytosis in rat insulinoma cells without affecting insulin content, the number of insulin granules at the plasma membrane, or the expression levels of key proteins involved in insulin secretion. Proteolysis of synaptosomal-associated protein of 25 kDa, a process involved in insulin granule exocytosis, is impaired in cells lacking PI3K-C2α. Finally, our data suggest that the mRNA for PI3K-C2α may be down-regulated in islets of Langerhans from type 2 diabetic compared with non-diabetic individuals. Our results reveal a critical role for PI3K-C2α in β cells and suggest that down-regulation of PI3K-C2α may be a feature of type 2 diabetes.

Indexed as

Down-RegulationExocytosisGene Expression Regulation, EnzymologicAnimalsCell Line, TumorDiabetes Mellitus, Type 2HumansInsulinInsulin-Secreting CellsInsulin SecretionIsoenzymesPhosphatidylinositol 3-KinasesRatsRNA, MessengerSecretory VesiclesSynaptosomal-Associated Protein 25InsulinIsoenzymesPhosphatidylinositol 3-KinasesPIK3C2A protein, humanRNA, MessengerSynaptosomal-Associated Protein 25

Identifiers

PMID21127054
PMCPMC3039383
OpenAlexW2044327593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.